Maynard Um
-
-
-
-
-
-
-
Lucid Capital Markets Starts Cassava Sciences (SAVA) at Buy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Cassava Sciences (SAVA) at Neutral
-
-
-
-
-
-
-
Cassava Sciences (SAVA) Licenses Simufilam Method of Treatment Patent
-
-
-
-
-
-
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
-
-
-
-
-
-
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - SAVA
-
-
-
-
-
-
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
-
-
-
-
-
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

